| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
B
Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709
Address all correspondence and requests for reprints to: John A. Cidlowski, P.O. Box 12233, MD E202, Research Triangle Park, North Carolina 27709. E-mail: Cidlowski{at}niehs.nih.gov
Glucocorticoids are primarily recognized for their profound
antiinflammatory actions and their ability to induce lymphocyte
apoptosis. We report here that, in contrast to their effect on cells of
the immune system, glucocorticoids suppress serum deprivation induced
apoptosis of rat hepatoma (HTC) cells. Suppression of apoptosis in
these cells occurs at physiological concentrations of glucocorticoid
and is abrogated by the glucocorticoid antagonist RU486. Although HTC
cells also express receptors for progesterone, estrogen, and thyroid
hormone, ligands for these receptors fail to rescue these cells from
programmed cell death. Because the sensitivity of cells to apoptotic
stimuli is often regulated by the ratio of antiapoptotic to
proapoptotic Bcl-2 family members, we analyzed the influence of
glucocorticoids and induction of apoptosis by serum starvation on the
expression of these proteins. Bcl-2, Bcl-xL, Bad, Bak, and
Bax levels were not altered by either treatment. Mitochondrial function
has recently been implicated as a critical early regulator of apoptosis
in many cells including hepatocytes. Dexamethasone treatment blocked a
decrease in this potential (
m) during serum
deprivation induced apoptosis in HTC cells, indicating an action of
this hormone upstream of mitochondria. We also show that the induction
of apoptosis in HTC cells is associated with a decrease in nuclear
factor (NF)-
B. Treatment with dexamethasone effectively blocked the
loss of nuclear NF-
B, suggesting that this hormone acts to suppress
apoptosis of HTC cells via regulation of this nuclear transcription
factor. This hypothesis was confirmed by transfection experiments that
show that expression of a superrepressor of NF-
B inhibits the
ability of dexamethasone to rescue HTC cells from apoptosis induced by
serum deprivation.
This article has been cited by other articles:
![]() |
S. Krishnan, K. A. Intlekofer, L. K. Aggison, and S. L. Petersen Central role of TRAF-interacting protein in a new model of brain sexual differentiation PNAS, September 29, 2009; 106(39): 16692 - 16697. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Harms, K. Albrecht, U. Harms, K. Seidel, L. Hauck, T. Baldinger, D. Hubner, G. Kronenberg, J. An, K. Ruscher, et al. Phosphatidylinositol 3-Akt-Kinase-Dependent Phosphorylation of p21Waf1/Cip1 as a Novel Mechanism of Neuroprotection by Glucocorticoids J. Neurosci., April 25, 2007; 27(17): 4562 - 4571. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsujimoto, T. Ono, M. Sato, T. Nishida, T. Oguma, and T. Tadakuma Regulation of the Expression of Caspase-9 by the Transcription Factor Activator Protein-4 in Glucocorticoid-induced Apoptosis J. Biol. Chem., July 29, 2005; 280(30): 27638 - 27644. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rosenhagen, C. Soti, U. Schmidt, G. M. Wochnik, F. U. Hartl, F. Holsboer, J. C. Young, and T. Rein The Heat Shock Protein 90-Targeting Drug Cisplatin Selectively Inhibits Steroid Receptor Activation Mol. Endocrinol., October 1, 2003; 17(10): 1991 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Herr, E. Ucur, K. Herzer, S. Okouoyo, R. Ridder, P. H. Krammer, M. von Knebel Doeberitz, and K.-M. Debatin Glucocorticoid Cotreatment Induces Apoptosis Resistance toward Cancer Therapy in Carcinomas Cancer Res., June 15, 2003; 63(12): 3112 - 3120. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Gascoyne, R. M. Kypta, and M. d. M. Vivanco Glucocorticoids Inhibit Apoptosis during Fibrosarcoma Development by Transcriptionally Activating Bcl-xL J. Biol. Chem., May 9, 2003; 278(20): 18022 - 18029. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Roca, R. M. Kypta, and M. d. M. Vivanco Loss of p16INK4a results in increased glucocorticoid receptor activity during fibrosarcoma development PNAS, March 18, 2003; 100(6): 3113 - 3118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. L. Leong, A. C. Maiyar, B. Kim, B. A. O'Keeffe, and G. L. Firestone Expression of the Serum- and Glucocorticoid-inducible Protein Kinase, Sgk, Is a Cell Survival Response to Multiple Types of Environmental Stress Stimuli in Mammary Epithelial Cells J. Biol. Chem., February 14, 2003; 278(8): 5871 - 5882. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kino and G. P. Chrousos Tumor Necrosis Factor alpha Receptor- and Fas-associated FLASH Inhibit Transcriptional Activity of the Glucocorticoid Receptor by Binding to and Interfering with Its Interaction with p160 Type Nuclear Receptor Coactivators J. Biol. Chem., January 24, 2003; 278(5): 3023 - 3029. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Barazzone-Argiroffo, A. Pagano, C. Juge, I. Metrailler, A. Rochat, C. Vesin, and Y. Donati Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-kappa B activity Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L197 - L204. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Brickley, C. A. Mikosz, C. R. Hagan, and S. D. Conzen Ubiquitin Modification of Serum and Glucocorticoid-induced Protein Kinase-1 (SGK-1) J. Biol. Chem., November 1, 2002; 277(45): 43064 - 43070. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Webster, R. M. Huber, R. L. Hanson, P. M. Collier, T. F. Haws, J. K. Mills, T. C. Burn, and E. A. Allegretto Dexamethasone and Tumor Necrosis Factor-{alpha} Act Together to Induce the Cellular Inhibitor of Apoptosis-2 Gene and Prevent Apoptosis in a Variety of Cell Types Endocrinology, October 1, 2002; 143(10): 3866 - 3874. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stankova, S. Turcotte, J. Harris, and M. Rola-Pleszczynski Modulation of Leukotriene B4 Receptor-1 Expression by Dexamethasone: Potential Mechanism for Enhanced Neutrophil Survival J. Immunol., April 1, 2002; 168(7): 3570 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Hu, R. G. Cowan, R. M. Harman, D. A. Porter, and S. M. Quirk Apoptosis of Bovine Granulosa Cells After Serum Withdrawal Is Mediated by Fas Antigen (CD95) and Fas Ligand Biol Reprod, February 1, 2001; 64(2): 518 - 526. [Abstract] [Full Text] |
||||
![]() |
C. Widen, J. Zilliacus, J.-A. Gustafsson, and A.-C. Wikstrom Glucocorticoid Receptor Interaction with 14-3-3 and Raf-1, a Proposed Mechanism for Cross-talk of Two Signal Transduction Pathways J. Biol. Chem., December 8, 2000; 275(50): 39296 - 39301. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Mikosz, D. R. Brickley, M. S. Sharkey, T. W. Moran, and S. D. Conzen Glucocorticoid Receptor-mediated Protection from Apoptosis Is Associated with Induction of the Serine/Threonine Survival Kinase Gene, sgk-1 J. Biol. Chem., May 11, 2001; 276(20): 16649 - 16654. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Demarchi, R. Verardo, B. Varnum, C. Brancolini, and C. Schneider Gas6 Anti-apoptotic Signaling Requires NF-kappa B Activation J. Biol. Chem., August 17, 2001; 276(34): 31738 - 31744. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |